2024 Kawasaki Disease Parent Symposium Q&A Questions (Transcribed) Q: How can families participate in the KD genetic studies? Who qualifies to enroll and how? A: Currently, DNA studies are focused on patients with aneurysms. Families with a child who...
Read More
Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association Kawasaki disease (KD) is an acute febrile illness mainly affecting children under 5 and is the leading cause of acquired heart disease in...
Editorial: Fostering Global Collaboration Around Kawasaki Disease. Reflections From the 14th International Kawasaki Disease Symposium From August 26 to August 29, the 14th International Kawasaki Disease Symposium (IKDS) was held in Montreal, Canada. For the past 40 years, IKDS...
Comparing Two Treatments for IVIG-Resistant Kawasaki Disease – Evidence Update for Clinicians Children with resistant KD who received infliximab were more likely to have their fever resolve within 24 hours than were children who received a second dose of...
Comparing Two Treatments for Resistant Kawasaki Disease – Evidence Update for Parents Compared with children who received a second dose of IVIG, children who received infliximab were more likely to have their fever end within 24 hours. Children who...
Navigating Kawasaki Disease Together: A Dialogue with Experts for Patients and Caregivers The Kawasaki Disease Foundation teamed up with Kawasaki Disease Canada to host a symposium titled “Navigating Kawasaki Disease Together: A Dialogue with Experts for Patients...
Control Participants Needed: individuals with no history of KD and who are not first relatives of someone with a history of KD The Kawasaki Disease Research Center at the University of California, San Diego, is looking for participants for...
KD Newsletter from Dr. Jane Burns The KD Summer Newsletter from Dr. Jane C. Burns addresses updates on the Covid-19 vaccine, KD Cases in San Diego during Covid-19, and new research opportunities. Read the complete newsletter here: KD Newsletter-Summer2021....
Ask the KD Experts: Is the COVID-19 vaccine safe for children and adults with a history of Kawasaki disease? The following update was provided by Jane Burns, M.D. Professor and Director, Kawasaki Disease Research Center. We understand that there...
THE DIAGNOSIS AND MANAGEMENT OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) WITH DR. ADRIANA TREMOULET Summary Four weeks after a COVID exposure, children may not be entirely in the clear. MIS-C is a post-infectious inflammatory state that affects pediatric...